Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
37254 | 63 | 37.8 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
2491 | 2 | MAMMARY GLAND//JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA//MAMMARY STEM CELLS | 3918 |
37254 | 1 | 3D SPHEROID ASSAYS//BORTENAT//EARLY EVENTS IN BREAST TUMORIGENESIS | 63 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 3D SPHEROID ASSAYS | authKW | 484694 | 2% | 100% | 1 |
2 | BORTENAT | authKW | 484694 | 2% | 100% | 1 |
3 | EARLY EVENTS IN BREAST TUMORIGENESIS | authKW | 484694 | 2% | 100% | 1 |
4 | ENVIRONM HLTH SCI MOL CELLULAR TOXICOL | address | 484694 | 2% | 100% | 1 |
5 | EPITHELIAL PARACRINE INTERACTIONS | authKW | 484694 | 2% | 100% | 1 |
6 | ESOPHAGEAL SQUAMOUS CELL CARCINOMA CELL LINES | authKW | 484694 | 2% | 100% | 1 |
7 | FOXO 3A | authKW | 484694 | 2% | 100% | 1 |
8 | FOXO 4 | authKW | 484694 | 2% | 100% | 1 |
9 | GLOBAL RD INFORMAT | address | 484694 | 2% | 100% | 1 |
10 | HUMAN BREAST PREMALIGNANT AND TUMOR EPITHELIAL CELLS | authKW | 484694 | 2% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1076 | 67% | 0% | 42 |
2 | Pathology | 26 | 6% | 0% | 4 |
3 | Chemistry, Medicinal | 23 | 6% | 0% | 4 |
4 | Biochemical Research Methods | 17 | 6% | 0% | 4 |
5 | Genetics & Heredity | 16 | 8% | 0% | 5 |
6 | Biochemistry & Molecular Biology | 9 | 14% | 0% | 9 |
7 | Cell Biology | 4 | 6% | 0% | 4 |
8 | Multidisciplinary Sciences | 4 | 2% | 0% | 1 |
9 | Biotechnology & Applied Microbiology | 4 | 5% | 0% | 3 |
10 | Pharmacology & Pharmacy | 2 | 6% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENVIRONM HLTH SCI MOL CELLULAR TOXICOL | 484694 | 2% | 100% | 1 |
2 | GLOBAL RD INFORMAT | 484694 | 2% | 100% | 1 |
3 | SKY CORE OURCE IL | 242346 | 2% | 50% | 1 |
4 | TRG ONCOL GYNECOL THER Y | 242346 | 2% | 50% | 1 |
5 | SMALL MOL CRYSTALLOG | 161563 | 2% | 33% | 1 |
6 | TARGET DISCOVERY TECHNOL | 161563 | 2% | 33% | 1 |
7 | TUIT | 161563 | 2% | 33% | 1 |
8 | MOL TRANSLAT MED PROGRAM | 121172 | 2% | 25% | 1 |
9 | YONSEI BIOMOL INITIAT | 80781 | 2% | 17% | 1 |
10 | BIOMED GENET SECT | 60585 | 2% | 13% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BREAST CANCER RESEARCH AND TREATMENT | 3283 | 11% | 0% | 7 |
2 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2241 | 5% | 0% | 3 |
3 | INTERNATIONAL JOURNAL OF ONCOLOGY | 811 | 6% | 0% | 4 |
4 | JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA | 789 | 2% | 0% | 1 |
5 | CANCER CELL INTERNATIONAL | 631 | 2% | 0% | 1 |
6 | GENES CHROMOSOMES & CANCER | 610 | 3% | 0% | 2 |
7 | MOLECULAR CANCER THERAPEUTICS | 474 | 3% | 0% | 2 |
8 | JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 280 | 2% | 0% | 1 |
9 | AAPS PHARMSCITECH | 263 | 2% | 0% | 1 |
10 | ANTICANCER RESEARCH | 225 | 5% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHOONG, LY , LIM, SK , CHEN, YH , LOH, MCS , TOY, WY , WONG, CY , SALTO-TELLEZ, M , SHAH, N , LIM, YP , (2011) ELEVATED NRD1 METALLOPROTEASE EXPRESSION PLAYS A ROLE IN BREAST CANCER GROWTH AND PROLIFERATION.GENES CHROMOSOMES & CANCER. VOL. 50. ISSUE 10. P. 837-847 | 14 | 44% | 2 |
2 | KADOTA, M , YANG, HH , GOMEZ, B , SATO, M , CLIFFORD, RJ , MEERZAMAN, D , DUNN, BK , WAKEFIELD, LM , LEE, MP , (2010) DELINEATING GENETIC ALTERATIONS FOR TUMOR PROGRESSION IN THE MCF10A SERIES OF BREAST CANCER CELL LINES.PLOS ONE. VOL. 5. ISSUE 2. P. - | 9 | 41% | 60 |
3 | CHOONG, LY , LIM, S , CHONG, PK , WONG, CY , SHAH, N , LIM, YP , (2010) PROTEOME-WIDE PROFILING OF THE MCF10AT BREAST CANCER PROGRESSION MODEL.PLOS ONE. VOL. 5. ISSUE 6. P. - | 13 | 31% | 17 |
4 | LIM, SJ , CHOI, HG , JEON, CK , KIM, SH , (2015) INCREASED CHEMORESISTANCE TO PACLITAXEL IN THE MCF10AT SERIES OF HUMAN BREAST EPITHELIAL CANCER CELLS.ONCOLOGY REPORTS. VOL. 33. ISSUE 4. P. 2023 -2030 | 10 | 29% | 1 |
5 | SHAW, PG , CHAERKADY, R , WANG, T , VASILATOS, S , HUANG, Y , VAN HOUTEN, B , PANDEY, A , DAVIDSON, NE , (2013) INTEGRATED PROTEOMIC AND METABOLIC ANALYSIS OF BREAST CANCER PROGRESSION.PLOS ONE. VOL. 8. ISSUE 9. P. - | 10 | 26% | 10 |
6 | HEPPNER, GH , MILLER, FR , SHEKHAR, PVM , (2000) NONTRANSGENIC MODELS OF BREAST CANCER.BREAST CANCER RESEARCH. VOL. 2. ISSUE 5. P. 331 -334 | 7 | 44% | 107 |
7 | KIM, SH , ZUKOWSKI, K , NOVAK, RF , (2009) RAPAMYCIN EFFECTS ON MTOR SIGNALING IN BENIGN, PREMALIGNANT AND MALIGNANT HUMAN BREAST EPITHELIAL CELLS.ANTICANCER RESEARCH. VOL. 29. ISSUE 4. P. 1143-1150 | 7 | 35% | 13 |
8 | WANG, YZ , HAN, YS , MA, YS , JIANG, JJ , CHEN, ZX , WANG, YC , CHE, W , ZHANG, F , XIA, Q , WANG, XF , (2012) DIFFERENTIAL GENE EXPRESSION OF WNT SIGNALING PATHWAY IN BENIGN, PREMALIGNANT, AND MALIGNANT HUMAN BREAST EPITHELIAL CELLS.TUMOR BIOLOGY. VOL. 33. ISSUE 6. P. 2317-2327 | 6 | 33% | 1 |
9 | LIM, S , CHOONG, LY , KUAN, CP , CHEN, YH , LIM, YP , (2009) REGULATION OF MACROPHAGE INHIBITORY FACTOR (MIF) BY EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IN THE MCF10AT MODEL OF BREAST CANCER PROGRESSION.JOURNAL OF PROTEOME RESEARCH. VOL. 8. ISSUE 8. P. 4062 -4076 | 9 | 21% | 10 |
10 | MAGUIRE, SL , PECK, B , WAI, PT , CAMPBELL, J , BARKER, H , GULATI, A , DALEY, F , VYSE, S , HUANG, P , LORD, CJ , ET AL (2016) THREE-DIMENSIONAL MODELLING IDENTIFIES NOVEL GENETIC DEPENDENCIES ASSOCIATED WITH BREAST CANCER PROGRESSION IN THE ISOGENIC MCF10 MODEL.JOURNAL OF PATHOLOGY. VOL. 240. ISSUE 3. P. 315 -328 | 10 | 14% | 0 |
Classes with closest relation at Level 1 |